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Abstract
 
Secretion of proteases is critical for degradation of the extracellular matrix during an inflamma-
tory response. Cathepsin (Cat) S and L are the major elastinolytic cysteine proteases in mouse
macrophages. A 65 amino acid segment of the p41 splice variant (p41
 
65aa
 
) of major histocom-
patibility complex class II–associated invariant chain (Ii) binds to the active site of CatL and
permits the maintenance of a pool of mature enzyme in endosomal compartments of macro-
phages and dendritic cells (DCs). Here we show that interaction of p41
 
65aa
 
 with mature CatL
allows extracellular accumulation of the active enzyme. We detected mature CatL as a complex
with p41
 
65aa
 
 in culture supernatants from antigen-presenting cells (APCs). Extracellular accu-
mulation of mature CatL is up-regulated by inflammatory stimuli as observed in interferon
(IFN)-
 
 
 
–treated macrophages and lipopolysaccharide (LPS)-activated DCs. Despite the neutral
pH of the extracellular milieu, released CatL associated with p41
 
65aa
 
 is catalytically active as
demonstrated by active site labeling and elastin degradation assays. We propose that p41
 
65aa
 
 sta-
bilizes CatL in the extracellular environment and induces a local increase in the concentration
of matrix-degrading enzymes during inflammation. Through its interaction with CatL, Ii may
therefore control the migratory response of APCs and/or the recruitment of effectors of the
inflammatory response.
Key words: protease • invariant chain • secretion • antigen-presenting cells • extracellular 
matrix degradation
 
Introduction
 
Lysosomal proteases of the cathepsin (Cat) family play a
critical role in antigen processing and in the formation of
peptide-receptive dimers during MHC class II–restricted
antigen presentation (1, 2). These enzymes are further-
more involved in the remodeling of extracellular matrix
proteins (3). Destruction of elastin-rich tissue during in-
flammatory responses is associated with a local accumula-
tion of macrophages that contain high levels of a variety
of elastinolytic enzymes. These cells secrete metallo-,
serine-, and cysteine proteases into extracellular space to
degrade matrix components. As elastin is resistant to most
forms of proteolytic attack (4, 5), both the sources and the
regulation of the enzymes involved in its dissolution are
of major interest.
Major elastinolytic cysteine proteases of the cathepsin
family are CatS, CatK, and CatL. The expression of CatK
in mouse macrophages is still a matter of debate. CatS and
CatL are synthesized as inactive proenzymes (3, 6), a fea-
ture shared by most lysosomal hydrolases. For the different
cathepsins, the propiece is located at the NH
 
2
 
 terminus and
can vary in size. The role of the propiece in the maturation
from precursor to active protease resembles the role of in-
variant chain (Ii) in MHC class II maturation. Ii serves as a
chaperone to facilitate the folding and assembly of class II
 
  
 
 dimers, addresses them to the endocytic pathway, and
blocks their antigen binding site, thus preventing their pre-
mature interaction with endogenous substrates (1, 2, 7).
Similarly, the occupancy of the enzyme active site by the
propiece stabilizes the protease conformation at neutral pH
(3, 8). In the endocytic pathway, the drop in pH promotes
removal of the propiece and proteolytic conversion to the
active, mature protease. With the exception of CatS, which
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is so far thought to be unique in its ability to survive and
maintain enzymatic activity at neutral pH (9, 10), most en-
dosomal hydrolases are unstable under such conditions (3).
While many cell types secrete cathepsins only as proforms,
activated macrophages have been reported to secrete ma-
ture enzymes (11). How mature forms of proteases survive
in the extracellular space is an important point that remains
to be resolved.
The CatL proregion consists of 96 amino acids (12). The
mature active forms of CatL are the single-chain (30 kD)
and the two-chain forms, composed of a 24/25 kD heavy-
chain linked to a 5 kD light-chain by disulfide bonds (3, 6).
The CatL two-chain forms are prevalent in cells from the
monocytic lineage. The protein and activity levels of this
mature form of CatL are controlled by MHC class II–asso-
ciated Ii in APCs (13).
In mice, Ii is synthesized as two major isoforms, p31 and
p41, which are distinguished by alternative splicing of Ii
transcripts (14, 15). Mice that express either p31 or p41
have been extensively characterized (13, 16, 17). The p41
isoform contains an extra 65 amino acid segment (p41
 
65aa
 
)
that resembles a cysteine-rich thyroglobulin type-1 do-
main. Both Ii isoforms function as chaperones for class II
folding and intracellular trafficking (16, 17). P31 and p41
are expressed in different ratios in the various types of
APCs. Whereas p41 represents only 10% of the total pool
of Ii in splenocytes, its expression level is considerably
higher in macrophages, dendritic cells (DCs) and Langer-
hans cells (18, 19). P41
 
65aa
 
 was found noncovalently bound
to the mature form of CatL purified from human kidney
(20). The x-ray crystallography analysis of the CatL/p41
 
65aa
 
complex revealed that the fragment occupies the active site
of the enzyme in the manner of a competitive inhibitor
(21). We found that the levels of mature CatL are consider-
ably decreased in cells that lack p41. Therefore we pro-
posed that p41 stabilizes the conformation of mature CatL
by binding to its active site, thus serving as a chaperone to
help maintain a pool of mature enzyme in endocytic com-
partments of APCs (13).
Interaction of active, endocytic proteases with competi-
tive inhibitors has been proposed as a mechanism to allow
their survival in extracellular space. Such a scenario was in-
voked for CatK for which a stable, secretory complex with
Cystatin C (CysC) was described (22). Unlike free mature
CatL, the enzyme complexed to p41 can survive in a neu-
tral pH environment (20). We therefore investigated the
possibility that p41
 
65aa
 
 promotes extracellular accumulation
of active mature CatL released from APCs.
 
Materials and Methods
 
Mice.
 
C57BL/6 and Ii
 
 
 
/
 
 
 
 mice were purchased from the
The Jackson Laboratory. CatL
 
 
 
/
 
 
 
, p31, and p41 mice have been
described (10, 13, 16, 17, 23).
 
Preparation of Bone Marrow–derived APCs.
 
Bone marrow from
2–4 mo mice were cultured in RPMI 1640/10% FCS/10 ng/ml
rmGM-CSF (PeproTech). Macrophages were harvested at day 5
(13) and activated with 100 U/ml rmIFN-
 
 
 
 for 2 d. To isolate
pure DCs, magnetic cell sorting with anti-CD11c beads was per-
formed (MACS; Miltenyi Biotec). To control proper separation,
anti-CD11c or anti-I-A
 
b
 
 (BD Biosciences) FACScan™ analysis
(Becton Dickinson) was performed. DCs were activated with
LPS (1 
 
 
 
g/ml) overnight.
 
Preparation of Cell Culture Supernatants.
 
Macrophages and DCs
were incubated overnight in FCS-free RPMI/GM-CSF. Super-
natants were harvested, centrifuged (5 min, 200 
 
g
 
) and analyzed.
The pH was monitored throughout the experiments and was close
to pH7, unless modified with citric acid.
 
Gel Filtration.
 
Experiments were performed to preserve
CatL/p41 interaction (20). Ammonium sulfate precipitation was
performed from supernatant of 
 
 
 
10
 
7
 
 cells. Precipitate was resus-
pended in 200 
 
 
 
l 50 mM sodium acetate, pH 5.0/1 mM EDTA.
Sample were fractionated on a Superdex 75 column HR 10/30
(Amersham Biosciences). Immunoblots with anti-CatL and anti-
p41 sera were performed on each fraction (60 
 
 
 
l).
 
Antibodies and Immunoblotting.
 
Experiments were performed
as described (13). Reagents were from A. Erickson (anti-CatL)
and E. Weber (anti-CatD and S). The JV7 serum is directed
against a peptide in the p41
 
65aa
 
 fragment (13).
 
Active Site Labeling.
 
DCG-04 was synthesized as described
(24, 25). PH was adjusted with citric acid (pH 3.0) to a range
from 4.5–6.5. 50 
 
 
 
l supernatant was incubated with DCG-04 (fi-
nal concentration 10 
 
 
 
M) for 1 h at 37
 
 
 
C. Reactivity of DCG-
04 with active cysteine proteases was detected as described (13).
 
Elastin Degradation Assays.
 
Elastinolytic activity in superna-
tants was analyzed with Elastin-Remazol microspheres (Elastin
Products Co.) according to the manufacturers’ protocol. 50 
 
 
 
l of
an Elastin-Remazol suspension (10 mg/ml in PBS/EDTA) was
reacted with 100 
 
 
 
l of fivefold concentrated supernatants for 8 h
at 37
 
 
 
C. After centrifugation, 100 
 
 
 
l was reacted with 50 
 
 
 
l of
0.2 M Tris, pH 8.8. Optical density (OD) was measured at 590
nm. Incubation of the Elastin-Remazol suspension with medium
alone was used to define the background. All experiments were
performed in the presence of EDTA and PMSF (100 
 
 
 
M). In se-
lected experiments, DCG-04 (10 
 
 
 
M) was added.
 
Results
 
P41-Ii Promotes Accumulation of Extracellular Mature CatL
in Macrophage Supernatants.
 
The p41 isoform of Ii main-
tains a pool of mature enzyme in endocytic compartments
of bone marrow-derived macrophages by means of a direct
interaction (13, 20; Fig. 1 A). What functional role does
this interaction between CatL and p41 play in APCs? One
possibility is that CatL bound to p41 is packaged into vesi-
cles of endosomal origin and released into extracellular
space since, unlike free mature CatL, this complex can sur-
vive at neutral pH. We analyzed supernatants from IFN-
 
 
 
–
treated macrophages of WT, CatL (CatL
 
 
 
/
 
 
 
), and Ii
knockout (Ii
 
 
 
/
 
 
 
) mice for the presence of CatL. Superna-
tants from cells that contain only the p31 or only the p41
splice variant of Ii were investigated (referred to as p31 and
p41). Expression of proCatL is independent of p41, and
anti-CatL immunoblotting experiments indeed showed
presence of equal amounts of CatL zymogen in superna-
tants from all strains (Fig. 1 B). In contrast, the secreted 24
kD mature form of CatL was detected only in supernatants
from WT and p41 macrophages, but not in Ii
 
 
 
/
 
 
 
 or p31-
derived samples (Fig. 1 B). As all supernatants contain large 
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amounts of proCatL, extracellular activation of proforms
can be ruled out as a mechanism for the generation of ma-
ture CatL. We performed an anti-CatS blot on the same
supernatants and detected equal amounts of pro- and ma-
ture CatS in all samples (Fig. 1 B). Thus, accumulation of
mature extracellular CatL is selectively regulated by the
presence of p41. A comparison of supernatants prepared
from untreated and stimulated macrophages shows the
same pattern of accumulation, with considerably lower lev-
els of mature CatL but larger amounts of proCatL in super-
natants from untreated cells (Fig. 1 C).
The possibility that mature CatL in supernatants from wt
or p41 mice is simply derived from cell leakage is ruled out
by the comparative analysis for intracellular protease con-
tent. We detect intracellular proforms of CatL and the ma-
ture-25 kD CatL in all macrophages but the CatL
 
 
 
/
 
 
 
 (Fig.
1 A). As expected, the expression of the 24 kD form of
CatL was restricted to cells that express p41 (13). If cell
leakage had occurred, it should have resulted in the detec-
tion of mature-25 kD CatL in supernatants from li
 
 
 
/
 
 
 
 and
p31 mice, as sufficient amounts are present inside the cells.
We therefore conclude that p41 is required for detection of
extracellular mature CatL.
 
Extracellular Accumulation of Mature CatL Is Up-regulated
during Activation of DCs.
 
Do these observations extend to
bone marrow–derived DCs? We show that DCs also re-
quire the presence of intracellular p41 for expression of
mature-24 kD CatL (13; Fig. 2 A). In line with this result,
we find that extracellular accumulation of mature CatL is
impaired in DCs that lack p41 (Fig. 2 B). In addition, sig-
nificantly larger amounts of mature-24 kD CatL are de-
tected in supernatants collected from LPS-activated DCs
(Fig. 2 B).
Analysis of intracellular protease content of DCs shows
that the pool of intracellular CatL is slightly downregulated
by LPS (Fig. 2 A) and that more of the mature enzyme is
found in the supernatant (Fig. 2 B). This suggests that the
mechanism of release of mature CatL is specifically up-reg-
ulated during DC activation, consistent with a role for
CatL secretion in the course of inflammation.
 
Mature CatL Accumulates in the Extracellular Space in Asso-
ciation with p41
 
65aa
 
.
 
To demonstrate that extracellular ma-
ture CatL is indeed associated with the p41 isoform of Ii,
we analyzed supernatants from wt, CatL
 
 
 
/
 
 
 
, Ii
 
 
 
/
 
 
 
, p31,
Figure 1. Intra- and extracellular CatL. (A) Intracellular expression of CatL and
CatS. Exposure time was adjusted to visualize mature, but not proCatL. The mature-
25 kD enzyme is present in all samples but CatL / . Mature-24 kD CatL is coex-
pressed with p41. CatS is evenly detected in all samples. (B) Analysis of macrophage
supernatants. ProCatL is detected in supernatants from all mouse strains. Mature
CatL is detected only in wt and p41supernatants, but is absent from Ii /  or p31
samples. Pro- and mature CatS are detected evenly in all samples irrespective of Ii
expression. (C) Comparison of supernatants from resting and activated macrophages.
Accumulation of extracellular mature CatL is up-regulated by IFN- .
Figure 2. Expression and release of CatL from resting and activated
DCs. (A) Levels of intracellular CatL are slightly downregulated by DC
activation. (B) Significantly larger amounts of mature CatL accumulate in
supernatants from activated DCs. Reprobing of the membrane shows
modest upregulation of proCatD secretion during activation. 
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and p41 macrophages for the presence of p41. An anti-
p41
 
65aa
 
 serum-reactive protein fragment of 
 
 
 
10 kD, corre-
sponding to the size of the previously described p41
 
65aa
 
, is
detected only in supernatants that contain mature CatL
(Fig. 3 A). No full-length p41 is found extracellularly (data
not depicted). Reprobing of the membrane with an anti-
CatD serum shows the presence of equal amounts of pro-
CatD in all samples (Fig. 3 A, top). The fact that p41
 
65aa
 
 is
detected only in 24 kD CatL-containing supernatants and
vice versa strongly suggests that these two proteins were se-
creted together.
To assess the presence of stable CatL/p41
 
65aa
 
 complexes,
supernatants from p41 cells were subjected to gel filtra-
tion. Subsequently, fractions were analyzed for the pres-
ence of CatL and p41. We observe perfect coelution of
mature-24 kD CatL and p41
 
65aa
 
 from the column, accord-
ing to its Stokes’ radius (Fig. 3 B, fractions 13–17). A pro-
tein fragment whose size (
 
 
 
16 kD) exceeds that of p41
 
65aa
 
elutes later than the CatL complex (Fig. 3 B, asterisk),
showing that p41
 
65aa
 
 must be associated with CatL to elute
at this position. These results show that mature CatL de-
tected in supernatants from APC cultures is associated
with p41
 
65aa
 
. Virtually the same results are obtained when
gel filtration is performed with supernatants from WT
cells (unpublished data).
 
Mature CatL is Accumulated in its Active Form.
 
Detection
of secreted, mature CatL requires expression of p41 (Fig.
1, B and C, and Figs. 2 B and 3, A and B). Unlike the free
mature enzyme, CatL complexed to p41 can survive at
neutral pH (20). Thus, the instability of extracellular ma-
ture CatL might be overcome by its interaction with
p41
 
65aa
 
. One would therefore predict that CatL bound to
p41
 
65aa
 
 maintains its enzymatic activity at neutral pH. To
test this hypothesis, we conducted active site labeling ex-
periments using DCG-04, a peptide epoxide derivative
that recognizes cysteine proteases (24, 25), and covalently
and irreversibly modifies their active site. The pH of the
supernatants was modified with citric acid (pH 3.0) to a
range from pH 6.5 to pH 4.5 before labeling (Fig. 4 A).
Only supernatants from p41 mice show considerable
amounts of active CatL at neutral pH (pH 7.5, Fig. 4 A).
No such activity is detected in supernatants from p31 mice
(Fig. 4 A). We detected active CatB and active CatS in all
samples, according to their expected pH activity ranges
and with their estimated MW (Fig. 4 A). As expected,
CatL was more active at low pH in contrast to CatS,
whose activity decreased under acidic conditions (Fig. 4
A). We conclude that p41
 
65aa
 
 allows survival and activity of
CatL at neutral pH, a condition so far considered as subop-
timal for this enzyme.
 
Active CatL Is the Major Elastin-degrading Enzyme at Neu-
tral pH.
 
We analyzed the ability of secreted active CatL to
degrade elastin as a physiologically relevant substrate. Elas-
tin microparticles coupled to remazol were incubated with
Figure 3. Extracellular mature CatL is detected as a complex with p4165aa. (A) Mature CatL is detected only in supernatants that contain p4165aa and
vice versa. (B) Gel filtration of the CatL/p4165aa complex. Mature CatL coelutes with p4165aa. A double exposure of a blot that was probed consecutively
with anti-CatL and anti-p4165aa sera is shown. An unknown band of  16 kD reactive with anti-CatL serum was detected (*, 17–21).
Figure 4. Extracellular mature CatL is active at neutral pH. (A) Active
site labeling of macrophage supernatants with DCG-04 at different pH.
Supernatants from p41 but not p31 mice contain active CatL. Active
CatB and CatS were detected in all samples. (B) Mature active CatL is
elastinolytic. Elastin-Remazol was incubated with macrophage superna-
tants at neutral pH. Enhanced elastinolytic activity is detected in superna-
tants from wt and p41 macrophages only. DCG-04 blocks elastinolytic
activity. Experiments (n   4) were performed in duplicates and are given
as mean   SEM. 
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macrophage supernatants at neutral pH. Degradation of this
modified elastin results in release of remazol from the ma-
trix, allowing a quantitative estimate of enzyme activity.
Significant elastinolysis at neutral pH is observed only in
supernatants from wt and p41 macrophages (Fig. 4 B). All
experiments were performed in the presence of EDTA and
PMSF which should inhibit matrix metallo- and serine
proteases (amongst which is the major elastase, CatG), and
therefore allows an assessment of the contribution of cys-
teine proteases to elastin degradation. Inclusion of DCG-04
in the experiment decreases elastinolytic activity signifi-
cantly (Fig. 4 B), showing that we indeed measure the ac-
tivity of a cysteine protease. Significantly lower elastinolytic
activity of CatL
 
 
 
/
 
 
 
 samples implies that neither matrix
metalloproteases nor CatB and CatS, despite their elastin-
destructive potential, contribute significantly in this assay
(Fig. 4 B). This stresses the notion that CatL is a major ac-
tive cysteine protease capable of degrading elastin in our
experimental setting. Auto-activation of proCatL and con-
version to the mature active enzyme could be expected
over the 8-h interval of the assay. However, the moderate
levels of elastinolytic activity observed in p31 samples indi-
cate that this mechanism is of lesser importance, if it occurs
at all. In summary, our data show that the CatL/p41
 
65aa
 
complex is a potentially active, complexed version of the
enzyme that can process physiologic substrates at neutral
pH, i.e., under conditions otherwise unfavorable for the
free mature enzyme.
 
Discussion
 
The p41 splice variant of MHC class II-associated Ii con-
tains a 65 aa segment that binds noncovalently to the active
site of CatL (20). We have previously documented the in
vivo significance of this CatL/p41 interaction by showing
that, in bone marrow–derived APCs, the levels of active
CatL are regulated by the presence of p41. The effect is
specific for the mature two-chain form of CatL. In particu-
lar, the mature-24 kD form, prevalent in activated APCs, is
lacking in cells that do not express p41 (13). In the present
study we are able to suggest a specific function for this
CatL/p41 complex. Indeed, we show that interaction of
p41 with CatL selectively regulates its accumulation as a
mature, active enzyme in the extracellular space of APCs.
This is inherent in the ability of p41
 
65aa
 
 to stabilize the con-
formation of CatL at neutral pH (20), therefore allowing its
survival in the extracellular milieu. Activated APCs (i.e.,
IFN-
 
 
 
–treated macrophages and LPS-activated DCs) se-
crete significantly more mature-24 kD CatL than resting
cells, suggesting that secretion of the CatL/p41
 
65aa
 
 complex
can be modulated by inflammatory stimuli. In addition, su-
pernatants that contain CatL/p41
 
65aa
 
 display increased elas-
tinolytic activity at neutral pH, pointing to CatL as a major
elastin-degrading protease produced by APCs. Together,
these data suggest that by controlling release of mature
CatL, the Ii, a component of the MHC class II antigen pre-
sentation pathway, can regulate degradation of the extra-
cellular matrix in the course of inflammation.
Figure 5. Model for regulation of extracellular CatL ac-
tivity by p41. (a–d) ProCatL can either be secreted or con-
verted to mature CatL intracellularly, independent of Ii.
The active, mature form CatL-24 kD is rapidly degraded
when p41 is absent. (e and f) By interaction with the active
site of CatL, the thyroglobulin domain of p41 protects the
mature enzyme from degradation. (g and h) Protected ma-
ture CatL can then be secreted into the extracellular milieu in
association with p4165aa. There, p4165aa bound to the active
site of CatL can be displaced by a physiological substrate of
the enzyme (e.g., elastin), which is subsequently hydrolyzed.1268 p41 Regulates Extracellular Accumulation of Active CatL
P4165aa allows the maintenance of a pool of latent active
CatL in late endosomal compartments of APCs (13). This
interaction stabilizes mature CatL and protects it from de-
struction by hydrolases. In the absence of p4165aa, the turn-
over of mature CatL in endosomal compartments is too fast
to allow significant accumulation and subsequent secretion
of the enzyme (see model; Fig. 5, a–c). This suggests that
CatL binds to p4165aa. intracellularly and that both mole-
cules are then secreted together as a stable complex (Fig. 5
g). This is supported by the fact that 24 kD CatL is de-
tected neither inside nor outside APCs that lack p41, and
that extracellular p4165aa does not accumulate in CatL-defi-
cient cells. Once in the extracellular milieu, engagement of
suitable substrates by the noncovalent CatL/p4165aa com-
plex might displace the p4165aa fragment thus allowing sub-
strate hydrolysis in a neutral pH environment (Fig. 5 h).
Our proposal for the function of p4165aa in secretion of
CatL is conceptually similar to the situation described for
CysC and CatK (22). CatK is found in the supernatants of
human macrophages in association with its endogenous in-
hibitor, CysC, thereby fulfilling the stability requirements
for mature CatK to survive at neutral pH. However, CatK
requires an acidic pH for elastinolytic activity (22). In con-
trast, interaction of p4165aa with CatL does not only stabi-
lize the protease, but extends the functional range of the
enzyme to activity at neutral pH. Though unlikely, our ex-
perimental setting does not formally rule out the possibility
that p4165aa interacts with CatL through an unidentified,
third protein and thereby regulates CatL activity indirectly.
The physiological relevance of CatL secretion may be
viewed in the context of cell migration, angiogenesis and
inflammatory response (5). Of note, extracellular activity of
CatL promotes tumor cell invasion, where massive secre-
tion of the enzyme is often connected to poor prognosis
(5). Angiogenesis is seen as an invasive process that requires
controlled release and activity of extracellular proteases
(26). In addition, CatL can generate the potent anti-angio-
genic molecule endostatin and thus modulate tumor vascu-
larization and expansion (27). Interestingly, expression of Ii
has been connected to tumor progression (28). Whether
this observation is linked to an increased ability of malig-
nant cells to secrete CatL remains to be examined.
Soluble CatL could be involved in the destruction of
elastin-rich tissue during the initiation of an inflammatory
response. Indeed, secreted active CatL has been shown to
play a role in degrading the extracellular matrix and to en-
hance migration of activated human macrophages (11). In-
creased secretion of mature CatL/p4165aa complex by acti-
vated APCs might contribute to matrix remodeling events
during the inflammatory response. Macrophages can acidify
their pericellular milieu to allow elastase activity in their
immediate microenvironment (29). The secretion of the
CatL/p4165aa complex active at neutral pH might allow
more expansive destruction of elastin-rich tissue and at a
greater distance. Degradation of the extracellular matrix
could be important for the activated APC to migrate to
lymph nodes to meet the appropriate T lymphocyte, as
well as for the recruitment of effectors of inflammation,
e.g., neutrophils and eosinophils. Therefore, future studies
should focus on comparing the response and behavior of
APCs from p31, p41, and CatL /  mice in different mod-
els of inflammation.
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